For specific guidance, see alcohol and semaglutide and alcohol and tirzepatide
In head-to-head clinical trial comparisons, semaglutide delivered 14.9% average weight loss at 68 weeks, while retatrutide achieved 24.2% weight loss at 48 weeks
Contact your GP if you experience: Unexplained weight gain that is persistent and cannot be attributed to dietary or lifestyle changes Weight gain accompanied by swelling in the legs, ankles, or abdomen that is not severe or sudden Fatigue, hair loss, feeling cold, or constipation alongside weight changes, which may indicate thyroid dysfunction Irregular or absent periods , excess hair growth, or acne in women, which may suggest PCOS or another hormonal disorder Weight changes associated with low mood, anxiety, or significant changes in appetite or sleep Any unexplained weight gain over a short period without a clear cause It is also worth reviewing your current medicines with a GP or pharmacist if you have recently started a new prescription and noticed weight changes
2 Recovering regained weight A Swiss study found that people using GLP-1 medications after bariatric surgery recovered an average of 67.4% of the weight they had regained
The FDAs ban seeks to protect public health by ensuring that only regulated, tested, and approved medications are available to patients
